$PFE, got FDA Approval on a cancer drug - biosimilar Nyvepria &amp; to add on top partner BioNTech secured funding for #COVID19 vaccine prod in Europe....may be a good place to park long term capital at 4.x% div- which is fairly safe. https://t.co/LcrlAr6EQZ